Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Does Medical Cannabis Help Reduce Involuntary Muscle Contractions in Dystonia? 

Posted
Updated
ByMy Patient Advice
Author: Dr. Clarissa Morton, PharmD

Current evidence suggests that medical cannabis may help reduce involuntary muscle contractions in some people with dystonia, but research is still limited and not yet strong enough for NHS approval. 

Studies show potential benefits, particularly with THC-dominant products, but most data come from small, observational studies rather than large clinical trials. This means that while some patients report improvement, results remain inconsistent and unproven. 

Does cancer-related care qualify for medical cannabis?

What We Know So Far 

Dystonia causes uncontrolled muscle contractions that can lead to twisting, tremors, or abnormal postures. It can affect one area or multiple parts of the body, often making everyday activities difficult. 

According to NHS guidance, medical cannabis is sometimes considered for severe, treatment-resistant conditions such as multiple sclerosis or epilepsy, but its use in dystonia is not currently supported by NICE or NHS policy. 

What The Evidence Shows 

A 2023 study in Frontiers in Neurology followed 23 people with dystonia who were prescribed medical cannabis for over two years. 

Key findings: 

  • Patients with widespread dystonia reported around 63% symptom reduction. 
  • Inhaled THC-dominant products were more effective than sublingual oils. 
  • Many reported less pain and better quality of life. 

A 2025 systematic review found that while cannabinoids show theoretical and early clinical promise, there is still no high-quality trial evidence confirming benefit for dystonia (PMC11839665, 2025). 

How It May Work 

THC (tetrahydrocannabinol) activates CB1 receptors in the brain’s movement control areas, such as the basal ganglia, potentially calming excessive nerve activity that leads to spasms. 

CBD (cannabidiol) may help by reducing inflammation and anxiety, although its effect on motor symptoms is less clear. 

Because the optimal dose, ratio, and delivery method are not yet defined, outcomes differ between individuals. 

The Clinical Bottom Line 

  • Some patients report reduced muscle contractions, especially with THC-dominant cannabis. 
  • Evidence remains limited and based on small-scale studies. 
  • NICE does not recommend cannabis for dystonia at this time. 
  • Controlled trials are needed before routine use can be advised. 

Safe Next Steps 

Providers like AlleviMed can explain eligibility and access pathways for medical cannabis under UK regulations. 

Anyone considering this option should speak with a specialist doctor familiar with unlicensed cannabis-based products. This ensures that treatment, if pursued, is safe, legal, and clinically supervised. 

Takeaway: 

Medical cannabis may ease involuntary muscle contractions for some people with dystonia, but proof is still emerging. For now, it remains a specialist-prescribed, unlicensed option, best explored under expert medical guidance. 

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories